[Ip-health] KEI asks FTC to block Celgene Acquisition of Juno Therapeutics, over BCMA-targeted CAR T treatment for Multiple Myeloma | Knowledge Ecology International
james.love at keionline.org
Fri Feb 16 09:49:11 PST 2018
KEI just asked the FTC to block the Celgene acquisition of Juno
Therapeutics, on the grounds that it would allow Celgene to control
competing CAR T treatments for multiple myeloma.
KEI met with the FTC on the merger on Wed.
A copy of our letter to the FTC, which we sent today, is here.
More information about the Ip-health